and PD share the feature of deposition of abnormally phosphorylated α-synuclein. A genome-wide association study of 1,713 white PD cases and 3,974 white control subjects also aimed to find significant associations with MSA. They identified an association with the SNCA locus in both diseases. The odds ratio (OR) associated with the heterozygous combination of the rs3857059 variant was 1.3 in both diseases (95% confidence interval (CI) in PD: 1.2 to 1.5; 95%CI in MSA: 1.1 to 1.6), whereas the OR for homozygous carriers was 3.8 (95%CI: 2.4 to 5.9) in PD and 5.9 (95%CI: 3.2 to 10.9) in MSA 3 . The rs3857059 variant of the SNCA gene has also been associated with an elevated mRNA expression level in the temporal cortex biopsies of patients with Alzheimer's disease with Lewy body pathology 4 . There is increasing evidence that genetic variants in the SNCA locus demonstrate associations with PD in several studies conducted in different populations 5, 6, 7 . Moreover, triplication of SNCA is related to early onset of PD, whereas, when duplicated, it associates with classical presentation of PD. This suggests that gene dosage affects the onset and progression of the disease. A recent study in a cellular model carrying a SNCA gene triplication demonstrated decreased developmental fitness, accelerated aging, and increased neuronal cell loss 8 . Besides copy number changes in the SNCA gene, three missense mutations are the most common pathogenic changes: A53T, A30P, and E46K
.
Nevertheless, a previous work from our group demonstrated the absence of the A30P change in the subset of patients analyzed in our group. Hence, different genetic variants in the SNCA gene may represent a risk factor for PD development in our population. The aim of the present work was to assess the possible association of the rs3857059 variant of the SNCA gene and PD in Mexican Mestizo patients.
METHOD
In total, 241 Mexican Mestizos were included in the study. Allele frequencies were compared between 106 patients diagnosed with PD and 135 controls. Controls were clinical healthy participants that were referred for neurological evaluation by a certified neurologist (García S). Only participants with no family history of PD or other neurodegenerative disorders were included. Samples were obtained from participants between February 2009 and June 2010, from four tertiarycare level hospitals in Mexico (Neurology Departments from Centro Médico Nacional "20 de Noviembre"-ISSSTE, Instituto de Ciencias Médicas y de la Nutrición "Salvador Zubirán, " Mexico City; and División de Genética, Centro de Investigación Biomédica de Occidente-IMSS, Jalisco, Mexico). Diagnosis was performed according to the Queen Square Brain Bank criteria 10 . Cognitive impairment was assessed using the Folstein Mini Mental State Examination Test. Institutional Committees approved the study and informed written consent was obtained from the participants.
Genomic DNA was isolated from peripheral blood leukocytes according to the method described by Gustincich et al.
11
; this technique allows high-quality DNA extraction for multiple applications due to the use of cationic detergents. Genotyping was performed by real time PCR using TaqMan probes (hydrolysis probes) specific for the rs3857059 (C_8933273_10 assay, Applied Biosystems, Foster City, CA, USA). Real-time PCR was performed on a LightCycler 480 II (Roche Diagnostics GmbH, Switzerland); PCR reactions were prepared according to the manufacturer's instructions. Statistical analysis was performed using SPSS software v. 18.0 (SPSS Inc., Chicago, IL, USA) and p < 0.05 were considered to indicate statistically significant results. Expected proportions of genotypes within each group were tested using the Hardy-Weinberg equilibrium (HWE), this was estimated using the χ2 test (available online http://ihg.gsf.de/cgi-bin/hw/hwa1.pl). Allele and genotype frequencies were compared between groups using the χ2 test and Fisher's exact test. To test for an association between the rs3857059 and PD, the χ2 test was performed. To estimate the proportion of the G allele of the rs3857059 variant in each study group, OR were calculated from 2 × 2 contingency tables. The association of this variant was also tested by gender using the 2 × 2 χ2 test. To test for differences in the age at onset and the genotype frequencies of the variant of interest, we performed one-way ANOVA. Then a Student's t-test was performed to test for differences in the mean age of onset between GG/AG and AA genotype groups. A χ2 test was also performed to test for an association between the variant and cognitive impairment.
RESULTS
Allele frequencies in our study were similar to those reported by the MEX group in the HAPMAP database (http://hapmap.ncbi.nlm.nih.gov/). Alleles and genotypes were distributed according to HWE equilibrium in both groups, consistent with unequivocal genotyping, which is the main factor affecting HWE deviations 12 ( Table 1 ). The χ2 test revealed that the G allele in the homozygous state (recessive model) was associated with PD (OR = 2.40, CI, 1.12 to 5.13, p = 0.02) ( Table 1) . Correction by regression was not necessary because no confounding factors were found as per the definition of Clarke et al. 13 . To test for an association of the variant by gender, we performed χ2 tests to compare the GG, AG, and AA genotypes in males and females separately, and a difference was found in the female group (p < 0.01) ( Table 2 ). The OR was estimated in females according to genotype in the following combinations: GG vs AA + AG using an allele positivity test table; association with PD was found only in females with the GG genotype (OR = 1.31, CI, 1.01 to 1.7, p = 0.037). We further analyzed the possible involvement of the variant in cognitive impairment, age at onset, and early onset in the youngest group of patients (< 40 years old); no association was found with any of these features (p > 0.05) ( Table 3) .
DISCUSSION
Allelic variants in various genes (PARK genes) have been linked to PD; for instance, the G2019S in the LRRK2 (PARK 8) gene confers major susceptibility to PD in Ashkenazi Jews and individuals from the north of Africa; whereas in Han Chinese populations, the rs7684318 variant of the SNCA gene (PARK1/4) was associated with PD but not with disease onset 14 . Therefore, major genes and specific variants associated with PD may be different among populations of distinct ethnic origin. Mexican Mestizos (most present-day Mexicans) are the result of the admixture of Spaniards and Amerindians 15 ; therefore, genetic variants associated with PD may be not the same as those frequently reported in other populations. Some studies conducted in Mexican Mestizos have gained insights into populationspecific genetic variants associated with PD, for example, the epsilon4 allele of APOE 16 for late-onset PD and variants in GBA and PARK2 in early-onset PD 17 . Nonetheless, major susceptibility genes remain unknown 18, 19 . Unlike in other ethnic groups, the A30P, IVS4 + 66A-G in SNCA, and other known point mutations in the PARK2 gene are uncommon in Mexican Mestizos 18, 20, 21 . The rs3857059 variant of the SNCA gene was associated with expression levels of SNCA mRNA in the temporal cortex of brain biopsies of patients with Alzheimer's & Lewy Body pathology; homozygotes for the minor allele (G) demonstrated significantly higher expression. Hence, we hypothesized that this genetic variant is associated with PD. To the best of our knowledge, this is the first study to find a positive association of the GG genotype of the rs3857059 variant and PD and also the first to find a gender effect, females with the GG genotype being more affected than males. Gender-based differences in gene expression in human dopaminergic neurons of substantia nigra pars compacta exist 22 ; however, SNCA upregulation was associated with PD in males 22 . In addition, methylation of the SNCA gene and its abnormal expression have been linked to behavioral disorders in females 23, 24 ; therefore, further studies are mandatory to gain insights into the gender effect of the GG genotype of the rs3857059 variant and PD reported herein.
A recent report from our group demonstrated that the rs1801133 variant in the MTHFR gene was associated with PD 25 . MTHFR is involved in many different biochemical pathways in humans, such as DNA methylation.
The expression of the SNCA gene is regulated in part by methylation of intron 1, because it was demonstrated in DNA derived from biopsies of substantia nigra, putamen, and cortex from PD patients 26 . Taken together, these findings suggest that, at least in Mexican Mestizos, allelic variants of the rs1801133 and rs3857059 in MTHFR and SNCA genes account for susceptibility to PD and the GG genotype of the rs3857059 variant is particularly associated with PD in females of this population. Further studies aimed to explore potential interactions between genetic and epigenetic changes involved in PD pathology may add to the complexity of this common neurodegenerative disorder.
